BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Cerity Partners LLC's Holding History (CIK: 0001566475)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 25,522 Value ($000) $194 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 28,764 Value ($000) $258 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 36,410 Value ($000) $273 Avg Close $8.07 Range $6.96 - $9.50

Q4 2024

Shares 11,992 Value ($000) $90 Avg Close $7.59 Range $6.85 - $8.44

Q3 2024

Shares 24,700 Value ($000) $188 Avg Close $7.60 Range $6.17 - $8.88

Q2 2024

Shares 11,634 Value ($000) $72 Avg Close $5.52 Range $4.03 - $6.99

Q1 2024

Shares 12,372 Value ($000) $63 Avg Close $5.62 Range $4.82 - $7.75

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	25,522	$194	$8.33	$7.42 - $9.23
Q2 2025	28,764	$258	$9.31	$6.02 - $11.31
Q1 2025	36,410	$273	$8.07	$6.96 - $9.50
Q4 2024	11,992	$90	$7.59	$6.85 - $8.44
Q3 2024	24,700	$188	$7.60	$6.17 - $8.88
Q2 2024	11,634	$72	$5.52	$4.03 - $6.99
Q1 2024	12,372	$63	$5.62	$4.82 - $7.75